CYCLERION THERAPEUTICS INC (CYCN) Stock News
NASDAQ:CYCN - Nasdaq - US23255M2044 - Common Stock - Currency: USD
CYCN Latest News, Press Relases and Analysis
CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q1 2024
Cyclerion Therapeutics just reported results for the first quarter of 2024.
CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cyclerion Therapeutics (NASDAQ:CYCN) just reported results for the fourth quart...
Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
Cyclerion Has Renegotiated Praliciguat License Agreement to Obtain Upfront and Near-Term Payments as well as Entered into a License Option Agreement for Olinciguat
CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023
Cyclerion Therapeutics just reported results for the fourth quarter of 2023.
Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
Cyclerion is leveraging its legacy sGC stimulator assets to generate near-term revenues which will be used to implement its strategic building plan....
Regina Graul, Ph.D., Promoted to Chief Executive Officer
Regina Graul, Ph.D., has been promoted to Chief Executive Officer, President, and member of the Board of Directors of Cyclerion....
Regina Graul, Ph.D., Promoted to Chief Executive Officer
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning!
Cyclerion Appoints Regina Graul, Ph.D., as President
– Dr. Graul will lead the rebuild of Cyclerion, bringing more than two decades of drug making experience, R&D portfolio leadership, and a deep...